JPMorgan upgrades BP to ‘overweight’

It noted that BP’s recent history has been chequered, with operational inconsistencies, strategic inconsistencies and a balance sheet poison pill.JPM said its ‘overweight’ these is centred on balance sheet repair, simplification, renewed long-term upstream growth optionality and a competitive valua…